Welcome to ACC's Cardio-Oncology Member Section!
Diego B. Sadler, MD, FACC
Chair
Novel and established cancer therapeutics have led to a substantial increase in cancer survivors. New therapeutics for cancer continue to grow exponentially, and a number of these therapies are associated with short and/or long-term adverse cardiovascular effects, some of which are unknown at this time. In addition to the risk of recurrent cancer, one of the greatest risks for cancer survivors is morbidity and mortality related to early and late cardiovascular toxicities.
The Cardio-Oncology clinicians strive to provide comprehensive cardiac care to patients who have co-existing heart disease and cancer, and to prevent and treat the cardiovascular complications of cancer therapeutics in patients undergoing cancer therapy and in cancer survivors. They aim to limit interruptions or delays in cancer therapy due to cardiovascular reasons.
The ACC Cardio-Oncology section strives to be the home for the ACC Cardio-Oncology clinicians, educators, researchers, and trainees across the stages of their careers. The section aims to support interest, education, and collaboration amongst the members in order to generate interest in this field, to advocate for and provide better care for their patients, to understand mechanisms of cardiovascular toxicity, and to grow the number of clinicians and programs with expertise in the cardiovascular care of patients with cancer and of cancer survivors.
We welcome your active participation!
Join the Cardio-Oncology Member Section — Today!
The Cardio-Oncology Member Section is only able to accomplish its mission through support from members. Members can join online by clicking here or by contacting ACC Member Care at (800) 253-4636, ext. 5603; or direct dial (202) 375-6000.
Already a member of the Cardio-Oncology Member Section? Click here to unlock the member exclusive section experience.
As our membership grows, so does the Cardio-Oncology Member Section's opportunities to impact College policies and provide additional member benefits.
Questions? Contact ACC Member Care.
Section Announcements
February 27, 2026
Connect with cardio-oncology professionals for conversation and collaboration at the Cardio-Oncology Section Meet-Up. Join fellow ACC Cardio-Oncology Section members on Saturday, March 28 from 5:30-6:30 p.m. CT in the Lounge & Learn Pavilion, Meet Up Zone 1. Register here.
Not yet registered for ACC.26? Register here and plan your program.
February 17, 2026
JACC: Case Reports is seeking high-impact case reports that advance clinical understanding of cardiac amyloidosis, encouraging submissions that showcase diagnostic challenges, therapeutic decision-making, emerging imaging or biomarker approaches, multidisciplinary care, or unusual presentations across the amyloid cardiomyopathy spectrum. Papers accepted for the special issue will be published with no article publishing charge. Learn more and submit by March 11.
February 17, 2026
A new JACC focus Issue on amyloid heart disease reflects “the rapid evolution of how we detect, stage and treat transthyretin amyloid cardiomyopathy,” writes JACC Editor-In-Chief Harlan M. Krumholz, MD, SM, FACC. Read new analyses from ATTRibute-CM, the 2025 ACC Concise Clinical Guidance on Transthyretin Cardiac Amyloidosis, studies examining treatment strategies and more. See the full issue.
Log in to MyACC
